Non Small Cell Lung Cancer

Development of RNAi-based anti-cancer therapeutics

Understanding the interactions between miRNAs with their specific cancer gene targets is an on-going effort to identify new therapeutic strategies. Researchers from University of Malaya carried out investigations to study ...

Jun 30, 2017
popularity1 comments 0

Cracks in the armor of therapy-resistant cancer cells

A new study shows that cancer cells across multiple lineages can adopt the same therapy-resistant cell state, enabling broad resistance to targeted therapies. However, the resulting cell circuitry also results in a vulnerability ...

Jul 06, 2017
popularity4 comments 0

Hope for better lung cancer treatment on horizon

A Melbourne study is set to improve treatment options for patients with the second most common type of lung cancer, lung squamous cell carcinoma, a disease for which new anti-cancer drugs are urgently needed.

Jun 13, 2017
popularity2 comments 0

Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy is increasingly being used both pre-operatively (neoadjuvant chemotherapy) and post-operatively (adjuvant chemotherapy).

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Screen time linked to diabetes

Daily screen time of three or more hours is linked to several risk factors associated with the development of diabetes in children, according to a study by St George's, University of London.

A new insight into Parkinson's disease protein

Abnormal clumps of certain proteins in the brain are a prominent feature of Parkinson's and other neurodegenerative diseases, but the role those same proteins might play in the normal brain has been unknown.